Mitra Modirian1, Shadi Rahimzadeh2, Zahra Cheraghi3, Ardeshir Khosravi4, Hamideh Salimzadeh5, Farzad Kompani6, Nazila Rezaei7, Mostafa Qorbani8, Alireza Delavari4, Maziar Moradi-Lakeh9, Farshad Farzadfar10. 1. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. f-farzadfar@tums.ac.ir, mazmoradi@yahoo.com. 2. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, TehranUniversity of Medical Sciences, Tehran, Iran, Departement of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran, Departement of Epidemiology, Tehran University of Medical Sciences, Tehran, Iran. 4. Iran Ministry of Health and Medical Education,Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. 5. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 6. Department of Hematology and Oncology, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran. 7. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, TehranUniversity of Medical Sciences, Tehran, Iran. 8. Departement of Public Health, Alborz University of Medical Sciences, Karaj, Iran, Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, TehranUniversity of Medical Sciences, Tehran, Iran, Departement of Epidemiology, Iran University of Medical Sciences, Tehran, Iran. 9. Community Medicine Department, Iran University of Medical Sciences, Tehran, Iran. 10. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, TehranUniversity of Medical Sciences, Tehran, Iran, Endocrinology and Metabolism Research center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND: Cancer registry can be a very important component of health information system in developing countries. Routine collection of data and ongoing monitoring of their quality can have a crucial role in priority setting and evidence-based policy making for controlling cancers and trends follow-up in low and middle-income countries. Evaluation of cancer registered data consists of four important components including: comparability, completeness, validity, and timeliness. Similar frameworks are utilized in different countries all over the world. METHODS AND MATERIALS: We will use the national annual cancer registry reports in Iran alone or perhaps along with other Iranian published reports about childhood cancer incidence to determine the stability and trend of incidence rates over time and compare above mentioned reports with childhood cancer incidence data reported by other countries through a systematic review as well as in some cases meta-analysis in order to assess data quality. Data will also be collected from other sources such as death certificates to estimate mortality rates and other different methods will also be additionally applied, by use of which death certificates would be utilized to assess the quality of data, too. CONCLUSION: As the first step for proper measuring incidence rate of all types of cancers all over the country, we will assess and evaluate reported national cancer registry data in Iran in order to estimate the national burden of cancers in 1990 - 2013.
BACKGROUND:Cancer registry can be a very important component of health information system in developing countries. Routine collection of data and ongoing monitoring of their quality can have a crucial role in priority setting and evidence-based policy making for controlling cancers and trends follow-up in low and middle-income countries. Evaluation of cancer registered data consists of four important components including: comparability, completeness, validity, and timeliness. Similar frameworks are utilized in different countries all over the world. METHODS AND MATERIALS: We will use the national annual cancer registry reports in Iran alone or perhaps along with other Iranian published reports about childhood cancer incidence to determine the stability and trend of incidence rates over time and compare above mentioned reports with childhood cancer incidence data reported by other countries through a systematic review as well as in some cases meta-analysis in order to assess data quality. Data will also be collected from other sources such as death certificates to estimate mortality rates and other different methods will also be additionally applied, by use of which death certificates would be utilized to assess the quality of data, too. CONCLUSION: As the first step for proper measuring incidence rate of all types of cancers all over the country, we will assess and evaluate reported national cancer registry data in Iran in order to estimate the national burden of cancers in 1990 - 2013.